Andrew John Phillips - 28 May 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Rogan Nunn, by power of attorney
Issuer symbol
OKUR
Transactions as of
28 May 2025
Net transactions value
$0
Form type
4
Filing time
30 May 2025, 16:54:43 UTC
Previous filing
10 Feb 2025
Next filing
09 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Andrew John Phillips filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 30 May 2025."

Quick Takeaways

  • This page summarizes Andrew John Phillips's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 30 May 2025, 16:54.

What Changed

  • Previous filing in this sequence was filed on 10 Feb 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Phillips Andrew John Director C/O ONKURE THEREAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER /s/ Rogan Nunn, by power of attorney 30 May 2025 0001921956

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OKUR Stock Option (right to buy) Award $0 +7,650 $0.000000 7,650 28 May 2025 Class A Common Stock 7,650 $2.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option will vest on the earlier of May 28, 2026 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.

Sponsored